nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—GHRHR—nervous system—attention deficit hyperactivity disorder	0.0189	0.0338	CbGeAlD
Docetaxel—GHRHR—central nervous system—attention deficit hyperactivity disorder	0.0182	0.0325	CbGeAlD
Docetaxel—GHRHR—cerebellum—attention deficit hyperactivity disorder	0.0178	0.0318	CbGeAlD
Docetaxel—GHRHR—brain—attention deficit hyperactivity disorder	0.0144	0.0258	CbGeAlD
Docetaxel—MAP4—forebrain—attention deficit hyperactivity disorder	0.0136	0.0244	CbGeAlD
Docetaxel—BCL2—forebrain—attention deficit hyperactivity disorder	0.0124	0.0222	CbGeAlD
Docetaxel—KIF11—brain—attention deficit hyperactivity disorder	0.0123	0.0219	CbGeAlD
Docetaxel—MAP4—cardiovascular system—attention deficit hyperactivity disorder	0.0115	0.0206	CbGeAlD
Docetaxel—MAPT—midbrain—attention deficit hyperactivity disorder	0.0115	0.0205	CbGeAlD
Docetaxel—TUBB8—nervous system—attention deficit hyperactivity disorder	0.0109	0.0194	CbGeAlD
Docetaxel—MAP2—forebrain—attention deficit hyperactivity disorder	0.0107	0.0192	CbGeAlD
Docetaxel—BCL2—cardiovascular system—attention deficit hyperactivity disorder	0.0105	0.0187	CbGeAlD
Docetaxel—TUBB8—central nervous system—attention deficit hyperactivity disorder	0.0105	0.0187	CbGeAlD
Docetaxel—MAP2—cardiovascular system—attention deficit hyperactivity disorder	0.00909	0.0162	CbGeAlD
Docetaxel—MAP4—midbrain—attention deficit hyperactivity disorder	0.00901	0.0161	CbGeAlD
Docetaxel—MAPT—cerebellum—attention deficit hyperactivity disorder	0.00887	0.0158	CbGeAlD
Docetaxel—TUBB4A—forebrain—attention deficit hyperactivity disorder	0.0083	0.0148	CbGeAlD
Docetaxel—TUBB8—brain—attention deficit hyperactivity disorder	0.0083	0.0148	CbGeAlD
Docetaxel—TUBB2B—forebrain—attention deficit hyperactivity disorder	0.00803	0.0143	CbGeAlD
Docetaxel—TUBB2A—forebrain—attention deficit hyperactivity disorder	0.00755	0.0135	CbGeAlD
Docetaxel—TUBB3—nervous system—attention deficit hyperactivity disorder	0.00741	0.0132	CbGeAlD
Docetaxel—MAP4—nervous system—attention deficit hyperactivity disorder	0.00741	0.0132	CbGeAlD
Docetaxel—TUBB1—nervous system—attention deficit hyperactivity disorder	0.00724	0.0129	CbGeAlD
Docetaxel—MAPT—brain—attention deficit hyperactivity disorder	0.0072	0.0129	CbGeAlD
Docetaxel—MAP4—central nervous system—attention deficit hyperactivity disorder	0.00713	0.0127	CbGeAlD
Docetaxel—TUBB3—central nervous system—attention deficit hyperactivity disorder	0.00713	0.0127	CbGeAlD
Docetaxel—MAP2—midbrain—attention deficit hyperactivity disorder	0.0071	0.0127	CbGeAlD
Docetaxel—TUBB4A—cardiovascular system—attention deficit hyperactivity disorder	0.00702	0.0125	CbGeAlD
Docetaxel—TUBB1—central nervous system—attention deficit hyperactivity disorder	0.00697	0.0125	CbGeAlD
Docetaxel—TUBB3—cerebellum—attention deficit hyperactivity disorder	0.00697	0.0125	CbGeAlD
Docetaxel—MAP4—cerebellum—attention deficit hyperactivity disorder	0.00697	0.0125	CbGeAlD
Docetaxel—BCL2—nervous system—attention deficit hyperactivity disorder	0.00673	0.012	CbGeAlD
Docetaxel—BCL2—central nervous system—attention deficit hyperactivity disorder	0.00648	0.0116	CbGeAlD
Docetaxel—TUBB4B—forebrain—attention deficit hyperactivity disorder	0.00648	0.0116	CbGeAlD
Docetaxel—TUBB6—cardiovascular system—attention deficit hyperactivity disorder	0.0063	0.0113	CbGeAlD
Docetaxel—EGFR—cerebellum—attention deficit hyperactivity disorder	0.00626	0.0112	CbGeAlD
Docetaxel—MAP2—nervous system—attention deficit hyperactivity disorder	0.00583	0.0104	CbGeAlD
Docetaxel—MAP4—brain—attention deficit hyperactivity disorder	0.00566	0.0101	CbGeAlD
Docetaxel—TUBB3—brain—attention deficit hyperactivity disorder	0.00566	0.0101	CbGeAlD
Docetaxel—MAP2—central nervous system—attention deficit hyperactivity disorder	0.00562	0.01	CbGeAlD
Docetaxel—TUBB1—brain—attention deficit hyperactivity disorder	0.00554	0.00989	CbGeAlD
Docetaxel—MAP2—cerebellum—attention deficit hyperactivity disorder	0.00549	0.00981	CbGeAlD
Docetaxel—TUBB4A—midbrain—attention deficit hyperactivity disorder	0.00548	0.0098	CbGeAlD
Docetaxel—TUBB4B—cardiovascular system—attention deficit hyperactivity disorder	0.00548	0.00978	CbGeAlD
Docetaxel—TUBB2B—midbrain—attention deficit hyperactivity disorder	0.0053	0.00947	CbGeAlD
Docetaxel—BCL2—brain—attention deficit hyperactivity disorder	0.00515	0.00919	CbGeAlD
Docetaxel—EGFR—brain—attention deficit hyperactivity disorder	0.00509	0.00908	CbGeAlD
Docetaxel—TUBB—midbrain—attention deficit hyperactivity disorder	0.00502	0.00896	CbGeAlD
Docetaxel—TUBB2A—midbrain—attention deficit hyperactivity disorder	0.00499	0.00891	CbGeAlD
Docetaxel—TUBB6—midbrain—attention deficit hyperactivity disorder	0.00492	0.00879	CbGeAlD
Docetaxel—TUBB4A—nervous system—attention deficit hyperactivity disorder	0.00451	0.00805	CbGeAlD
Docetaxel—MAP2—brain—attention deficit hyperactivity disorder	0.00446	0.00796	CbGeAlD
Docetaxel—TUBB2B—nervous system—attention deficit hyperactivity disorder	0.00436	0.00778	CbGeAlD
Docetaxel—TUBB4A—central nervous system—attention deficit hyperactivity disorder	0.00434	0.00775	CbGeAlD
Docetaxel—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.00434	0.00775	CbGeAlD
Docetaxel—ABCC10—midbrain—attention deficit hyperactivity disorder	0.00431	0.0077	CbGeAlD
Docetaxel—TUBB4B—midbrain—attention deficit hyperactivity disorder	0.00428	0.00764	CbGeAlD
Docetaxel—TUBB4A—cerebellum—attention deficit hyperactivity disorder	0.00424	0.00758	CbGeAlD
Docetaxel—TUBB2B—central nervous system—attention deficit hyperactivity disorder	0.00419	0.00749	CbGeAlD
Docetaxel—TUBB2A—nervous system—attention deficit hyperactivity disorder	0.0041	0.00733	CbGeAlD
Docetaxel—TUBB2B—cerebellum—attention deficit hyperactivity disorder	0.0041	0.00732	CbGeAlD
Docetaxel—TUBB6—nervous system—attention deficit hyperactivity disorder	0.00405	0.00723	CbGeAlD
Docetaxel—TUBB2A—central nervous system—attention deficit hyperactivity disorder	0.00395	0.00705	CbGeAlD
Docetaxel—TUBB6—central nervous system—attention deficit hyperactivity disorder	0.00389	0.00696	CbGeAlD
Docetaxel—TUBB—cerebellum—attention deficit hyperactivity disorder	0.00388	0.00693	CbGeAlD
Docetaxel—TUBB2A—cerebellum—attention deficit hyperactivity disorder	0.00386	0.00689	CbGeAlD
Docetaxel—SLC22A7—brain—attention deficit hyperactivity disorder	0.00385	0.00689	CbGeAlD
Docetaxel—TUBB6—cerebellum—attention deficit hyperactivity disorder	0.00381	0.0068	CbGeAlD
Docetaxel—TUBB4B—nervous system—attention deficit hyperactivity disorder	0.00352	0.00628	CbGeAlD
Docetaxel—TUBB4A—brain—attention deficit hyperactivity disorder	0.00345	0.00615	CbGeAlD
Docetaxel—TUBB4B—central nervous system—attention deficit hyperactivity disorder	0.00339	0.00605	CbGeAlD
Docetaxel—ABCC10—cerebellum—attention deficit hyperactivity disorder	0.00333	0.00595	CbGeAlD
Docetaxel—TUBB2B—brain—attention deficit hyperactivity disorder	0.00333	0.00595	CbGeAlD
Docetaxel—TUBB4B—cerebellum—attention deficit hyperactivity disorder	0.00331	0.00591	CbGeAlD
Docetaxel—TUBB—brain—attention deficit hyperactivity disorder	0.00315	0.00563	CbGeAlD
Docetaxel—TUBB2A—brain—attention deficit hyperactivity disorder	0.00313	0.0056	CbGeAlD
Docetaxel—TUBB6—brain—attention deficit hyperactivity disorder	0.00309	0.00552	CbGeAlD
Docetaxel—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00279	0.00497	CbGeAlD
Docetaxel—ABCC10—brain—attention deficit hyperactivity disorder	0.00271	0.00484	CbGeAlD
Docetaxel—TUBB4B—brain—attention deficit hyperactivity disorder	0.00269	0.0048	CbGeAlD
Docetaxel—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00268	0.00479	CbGeAlD
Docetaxel—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.00262	0.00468	CbGeAlD
Docetaxel—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00252	0.00451	CbGeAlD
Docetaxel—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00236	0.00421	CbGeAlD
Docetaxel—CYP1B1—brain—attention deficit hyperactivity disorder	0.00213	0.0038	CbGeAlD
Docetaxel—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00195	0.00349	CbGeAlD
Docetaxel—ABCC1—brain—attention deficit hyperactivity disorder	0.00191	0.00342	CbGeAlD
Docetaxel—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00188	0.00336	CbGeAlD
Docetaxel—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00159	0.00285	CbGeAlD
Docetaxel—ABCG2—brain—attention deficit hyperactivity disorder	0.00159	0.00283	CbGeAlD
Docetaxel—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00144	0.00258	CbGeAlD
Docetaxel—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00139	0.00248	CbGeAlD
Docetaxel—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00124	0.00222	CbGeAlD
Docetaxel—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00115	0.00262	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00262	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00115	0.00261	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00114	0.0026	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00113	0.00258	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00113	0.00257	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00113	0.00256	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00112	0.00256	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00112	0.00255	CbGpPWpGaD
Docetaxel—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.00112	0.00254	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00111	0.00252	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0011	0.00251	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00108	0.00245	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00107	0.00244	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00106	0.00241	CbGpPWpGaD
Docetaxel—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00105	0.0024	CbGpPWpGaD
Docetaxel—BCL2—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00104	0.00237	CbGpPWpGaD
Docetaxel—BCL2—Kit receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.00104	0.00237	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00104	0.00236	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00103	0.00235	CbGpPWpGaD
Docetaxel—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00102	0.00183	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00232	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00101	0.00229	CbGpPWpGaD
Docetaxel—BCL2—Validated targets of C-MYC transcriptional repression—EP300—attention deficit hyperactivity disorder	0.000988	0.00224	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000985	0.00224	CbGpPWpGaD
Docetaxel—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000985	0.00176	CbGeAlD
Docetaxel—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000962	0.00172	CbGeAlD
Docetaxel—GHRHR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000939	0.00213	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.000933	0.00212	CbGpPWpGaD
Docetaxel—ABCC10—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000916	0.00208	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000909	0.00206	CbGpPWpGaD
Docetaxel—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000893	0.00203	CbGpPWpGaD
Docetaxel—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000878	0.00199	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.000861	0.00196	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000826	0.00188	CbGpPWpGaD
Docetaxel—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000814	0.00185	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000808	0.00184	CbGpPWpGaD
Docetaxel—TUBB—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.000802	0.00182	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000798	0.00181	CbGpPWpGaD
Docetaxel—TUBB—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000791	0.0018	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00079	0.00179	CbGpPWpGaD
Docetaxel—BCL2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000785	0.00178	CbGpPWpGaD
Docetaxel—ABCB1—brain—attention deficit hyperactivity disorder	0.000782	0.0014	CbGeAlD
Docetaxel—GHRHR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00078	0.00177	CbGpPWpGaD
Docetaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000773	0.00176	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000771	0.00175	CbGpPWpGaD
Docetaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000771	0.00175	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000771	0.00175	CbGpPWpGaD
Docetaxel—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000763	0.00173	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000762	0.00173	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000761	0.00173	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000751	0.00171	CbGpPWpGaD
Docetaxel—EGFR—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000751	0.00171	CbGpPWpGaD
Docetaxel—GHRHR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000724	0.00165	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000714	0.00162	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000703	0.0016	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000681	0.00155	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00067	0.00152	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.000666	0.00151	CbGpPWpGaD
Docetaxel—TUBB4A—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.000665	0.00151	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000662	0.0015	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000658	0.00149	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000656	0.00149	CbGpPWpGaD
Docetaxel—TUBB4A—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000655	0.00149	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STUB1—attention deficit hyperactivity disorder	0.000635	0.00144	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000633	0.00144	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000626	0.00142	CbGpPWpGaD
Docetaxel—CYP1B1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000621	0.00141	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.000619	0.00141	CbGpPWpGaD
Docetaxel—CYP1B1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000617	0.0014	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.000614	0.0014	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000614	0.00139	CbGpPWpGaD
Docetaxel—TUBB4B—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.000608	0.00138	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.000607	0.00138	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000603	0.00137	CbGpPWpGaD
Docetaxel—TUBB4B—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.000599	0.00136	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000596	0.00135	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.000595	0.00135	CbGpPWpGaD
Docetaxel—TUBB6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000579	0.00132	CbGpPWpGaD
Docetaxel—TUBB2B—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000579	0.00132	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000564	0.00128	CbGpPWpGaD
Docetaxel—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00056	0.00127	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000559	0.00127	CbGpPWpGaD
Docetaxel—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000557	0.00126	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000555	0.00126	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.000555	0.00126	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000542	0.00123	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000537	0.00122	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00053	0.0012	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000526	0.0012	CbGpPWpGaD
Docetaxel—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000525	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000522	0.00118	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000491	0.00112	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000488	0.00111	CbGpPWpGaD
Docetaxel—BCL2—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000481	0.00109	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000476	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—EP300—attention deficit hyperactivity disorder	0.000473	0.00107	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.000443	0.00101	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000435	0.000988	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000433	0.000983	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000414	0.00094	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000413	0.000938	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000408	0.000927	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000407	0.000924	CbGpPWpGaD
Docetaxel—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000405	0.00092	CbGpPWpGaD
Docetaxel—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000402	0.000914	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000396	0.000899	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000393	0.000893	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000389	0.000883	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000388	0.000881	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00038	0.000863	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STUB1—attention deficit hyperactivity disorder	0.000375	0.000853	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EP300—attention deficit hyperactivity disorder	0.000375	0.000851	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000374	0.00085	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000368	0.000835	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000362	0.000823	CbGpPWpGaD
Docetaxel—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000355	0.000805	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000353	0.000802	CbGpPWpGaD
Docetaxel—EGFR—Disease—STUB1—attention deficit hyperactivity disorder	0.000347	0.000787	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000346	0.000786	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000311	0.000706	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000308	0.000701	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00029	0.000659	CbGpPWpGaD
Docetaxel—EGFR—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000285	0.000646	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000284	0.000645	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000281	0.000639	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000278	0.000631	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000271	0.000616	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000265	0.000601	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000258	0.000587	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000258	0.000587	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000256	0.000581	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000255	0.00058	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000254	0.000577	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000244	0.000555	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000243	0.000551	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000241	0.000546	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00024	0.000545	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000236	0.000537	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000233	0.000529	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000231	0.000524	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000228	0.000518	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000211	0.00048	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00021	0.000476	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000209	0.000474	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000207	0.000469	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000206	0.000468	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000204	0.000464	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0002	0.000455	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.000447	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000195	0.000443	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000193	0.000439	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00019	0.000431	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000189	0.00043	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000189	0.000429	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000188	0.000428	CbGpPWpGaD
Docetaxel—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000187	0.000425	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000185	0.000421	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000183	0.000416	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000183	0.000415	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000183	0.000415	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00018	0.000408	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000177	0.000401	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000177	0.000401	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000174	0.000396	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000174	0.000395	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000173	0.000393	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000171	0.000388	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000168	0.000382	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000167	0.000379	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000167	0.000379	CbGpPWpGaD
Docetaxel—EGFR—Disease—SNAP25—attention deficit hyperactivity disorder	0.000164	0.000373	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000162	0.000367	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000161	0.000365	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000161	0.000365	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000159	0.000362	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000159	0.000362	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000158	0.000359	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000157	0.000356	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000157	0.000356	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000155	0.000353	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000151	0.000342	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000147	0.000334	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000146	0.000332	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000146	0.000331	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000142	0.000322	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000141	0.000321	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000139	0.000316	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000134	0.000305	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000132	0.0003	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000128	0.000292	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000127	0.000289	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000126	0.000286	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000124	0.000281	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000122	0.000278	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000121	0.000276	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000121	0.000275	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000119	0.000271	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000115	0.000262	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000115	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000115	0.000261	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000113	0.000257	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000112	0.000255	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000111	0.000253	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000111	0.000251	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00011	0.00025	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000249	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000108	0.000246	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000107	0.000243	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000107	0.000242	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000106	0.000241	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000105	0.000239	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000103	0.000234	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000101	0.000229	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.93e-05	0.000226	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EP300—attention deficit hyperactivity disorder	9.78e-05	0.000222	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	9.74e-05	0.000221	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.67e-05	0.00022	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	9.65e-05	0.000219	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	9.58e-05	0.000218	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.21e-05	0.000209	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.76e-05	0.000199	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.69e-05	0.000197	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.69e-05	0.000197	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.55e-05	0.000194	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.95e-05	0.000181	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.76e-05	0.000176	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.06e-05	0.00016	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	6.98e-05	0.000158	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.95e-05	0.000158	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	6.93e-05	0.000157	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—attention deficit hyperactivity disorder	6.71e-05	0.000152	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.61e-05	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—attention deficit hyperactivity disorder	5.78e-05	0.000131	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	5.67e-05	0.000129	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.35e-05	0.000122	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.35e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—attention deficit hyperactivity disorder	5.34e-05	0.000121	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.27e-05	0.00012	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.26e-05	0.00012	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.23e-05	0.000119	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.9e-05	0.000111	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	4.75e-05	0.000108	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	4.59e-05	0.000104	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.28e-05	9.72e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.18e-05	9.49e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	4.14e-05	9.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.07e-05	9.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.74e-05	8.5e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.24e-05	7.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.22e-05	7.32e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	2.99e-05	6.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.26e-05	5.13e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.39e-05	3.16e-05	CbGpPWpGaD
